Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria

S Beinhardt; R Al Zoairy; C Freissmuth; K Kozbial; S Hametner; R Stern; RE Stauber; A Maieron; K Staufer; Michael Strasser; HM Zoller; I Graziadei; W Vogel; M Peck-Radosavljevic; M Trauner; P Ferenci; H Hofer

Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria

S Beinhardt, R Al Zoairy, C Freissmuth, K Kozbial, S Hametner, R Stern, RE Stauber, A Maieron, K Staufer, Michael Strasser, HM Zoller, I Graziadei, W Vogel, M Peck-Radosavljevic, M Trauner, P Ferenci, H Hofer

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog

Research output: Contribution to journal › Abstract (Journal) › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	746A-747A
Journal	HEPATOLOGY
Volume	62
Publication status	Published - 2015
Event	66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - San Francisco, CA Duration: 13 Nov 2015 → 17 Nov 2015

Cite this

Beinhardt, S., Al Zoairy, R., Freissmuth, C., Kozbial, K., Hametner, S., Stern, R., Stauber, RE., Maieron, A., Staufer, K., Strasser, M., Zoller, HM., Graziadei, I., Vogel, W., Peck-Radosavljevic, M., Trauner, M., Ferenci, P., & Hofer, H. (2015). Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria. HEPATOLOGY , 62, 746A-747A.

Beinhardt, S ; Al Zoairy, R ; Freissmuth, C et al. / Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria. In: HEPATOLOGY 2015 ; Vol. 62. pp. 746A-747A.

@article{ca792747d5f24a93935a32fa8b911275,

title = "Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria",

author = "S Beinhardt and {Al Zoairy}, R and C Freissmuth and K Kozbial and S Hametner and R Stern and RE Stauber and A Maieron and K Staufer and Michael Strasser and HM Zoller and I Graziadei and W Vogel and M Peck-Radosavljevic and M Trauner and P Ferenci and H Hofer",

year = "2015",

language = "English",

volume = "62",

pages = "746A--747A",

journal = "HEPATOLOGY ",

issn = "0270-9139",

note = "66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) ; Conference date: 13-11-2015 Through 17-11-2015",

}

Beinhardt, S, Al Zoairy, R, Freissmuth, C, Kozbial, K, Hametner, S, Stern, R, Stauber, RE, Maieron, A, Staufer, K, Strasser, M, Zoller, HM, Graziadei, I, Vogel, W, Peck-Radosavljevic, M, Trauner, M, Ferenci, P & Hofer, H 2015, 'Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria', HEPATOLOGY , vol. 62, pp. 746A-747A.

Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria. / Beinhardt, S; Al Zoairy, R; Freissmuth, C et al.
In: HEPATOLOGY , Vol. 62, 2015, p. 746A-747A.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria

AU - Beinhardt, S

AU - Al Zoairy, R

AU - Freissmuth, C

AU - Kozbial, K

AU - Hametner, S

AU - Stern, R

AU - Stauber, RE

AU - Maieron, A

AU - Staufer, K

AU - Strasser, Michael

AU - Zoller, HM

AU - Graziadei, I

AU - Vogel, W

AU - Peck-Radosavljevic, M

AU - Trauner, M

AU - Ferenci, P

AU - Hofer, H

PY - 2015

Y1 - 2015

M3 - Abstract (Journal)

SN - 0270-9139

VL - 62

SP - 746A-747A

JO - HEPATOLOGY

JF - HEPATOLOGY

T2 - 66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Y2 - 13 November 2015 through 17 November 2015

ER -

Beinhardt S, Al Zoairy R, Freissmuth C, Kozbial K, Hametner S, Stern R et al. Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria. HEPATOLOGY . 2015;62:746A-747A.